In 10-30% of hypertrophic cardiomyopathy kindreds, the disease is caused by >29 missense mutations in the cardiac f8-myosin heavy chain (AYIH7) gene. The amino acid sequence similarity between chicken skeletal muscle and human a-cardiac myosin and the three-dimensional structure of the chicken skeletal muscle myosin head have provided the opportunity to examine the structural consequences of these naturally occurring mutations in human ,8-cardiac myosin. This study demonstrates that the mutations are related to distinct structural and functional domains. Twenty-four are clustered around four specific locations in the myosin head that are (i) associated with the actin binding interface, (ii) around the nucleotide binding site, (iii) adjacent to the region that connects the two reactive cysteine residues, and (iv) in close proximity to the interface of the heavy chain with the essential light chain. The remaining five mutations are in the myosin rod. The locations of these mutations provide insight into the way they impair the functioning of this molecular motor and also into the mechanism of energy transduction.
The three-dimensional structure of a protein that has been implicated in a disease state is an important source of information for understanding the molecular basis of that state. This was first demonstrated by the pioneering studies on hemoglobin and sickle cell anemia (1) (2) (3) . Although for many proteins site-directed mutagenesis is now the investigative method of choice, the study of natural genetic lesions continues to be of enormous value as the source of information for understanding protein structure and function. (i) It provides one of the most powerful tools for identifying the proteins and genes involved in the disease state, and (ii) it indicates residues or sections of a molecule that are important for the normal function of the molecule.
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited cardiac disease, characterized by left ventricular hypertrophy and markedly variable phenotypic expression (4, 5) . It is the most common cause of sudden death in otherwise healthy young individuals. The disease is caused by missense mutations in the 13-myosin heavy chain (MHC) gene (MYH7) in 10-30% of HCM kindreds. More than 29 such mutations have been identified (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Most are associated with a high incidence of sudden death but a few have been associated with a more benign prognosis (4, 5) . All have been located in the globular head of myosin (subfragment 1, Si) or in the head-rod junction of the myosin molecule. The head region contains all the necessary elements to generate movement of actin relative to myosin during ATP hydrolysis (19, 20) . At this time, the three-dimensional structure of the human 3-cardiac myosin Si is unknown. However, much of the primary sequence of myosin is highly conserved (21) such that the three-dimensional structures of all myosin molecules are expected to be very similar (22) . Thus, it is possible to use the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
three-dimensional structure of chicken skeletal myosin Si to interpret the effects induced by the substitutions in the MYI7 gene (23, 24) . Conversely, the location of the mutations highlights important areas of the molecule and contributes to understanding the molecular basis of energy transduction.
We describe here, relative to the structure of chicken skeletal myosin Si, the location of 29 missense mutations in the ,3-cardiac myosin (MIYH7) gene that have been shown to cause HCM.
METHODS
The study of the location of homologous residues in the chicken skeletal structure consisted of 29 amino acid residue substitutions encoded by missense mutations in the MY7 gene. These HCMcausing mutations and their corresponding residues in the chicken fast skeletal muscle MHC are shown in Table 1 . The locations of the amino acid mutations were mapped onto the chicken structure by aligning the sequences of the human cardiac and chicken skeletal muscle myosins with the GCG program package (25) . There was 79% sequence identity between the two proteins in their respective myosin heads (26, 27) .
RESULTS
In all cases, the mutations in the cardiac amino acid sequence map to well-defined parts of the three-dimensional structure of chicken skeletal myosin Si (Table 1) . Throughout this paper, the mutations in the human MYI7 gene are indicated by the single-letter code for the normal and mutated amino acid, whereas the equivalent residue in the chicken amino acid sequence is indicated by its three-letter code. All of the discussion of the locations of amino acids is relative to the chicken skeletal muscle myosin numbering.
There is an extensive biochemical literature pertaining to the chemical and physical properties of myosin (28) . Much of this is described with respect to the three major tryptic fragments, an N-terminal 25-kDa fragment, a central 50-kDa fragment, and a C-terminal 20-kDa fragment, generated by mild digestion of myosin S1 (29, 30) . Although these peptides do not represent individual tertiary domains (23) , they are convenient for describing the three-dimensional location of the mutations.
The three-dimensional locations of the point mutations in the MYI7 gene as mapped onto the structure of chicken skeletal myosin S1 are shown in Fig. 1 and summarized in Table 1 . The proposed interpretation of the biochemical significance of these mutations is based in part on the model for the rigor actin-Sl complex (24) that was obtained by docking the structure of chicken Si onto that of filamentous actin (32) within the constraints of the helical reconstruction of electron micrographs of rigor actin-Sl (33, 34 tTo whom reprint requests should be addressed. particular, one group is associated with the actin binding interface, a second is close to the active site, and a third group is close to the interface of the heavy chain with the essential light chain (ELC). A fourth group is adjacent to the region that connects the two reactive cysteine residues, Cys-697 and Cys-707 in the chicken sequence. The remaining mutations are found in the myosin rod. The specific environments of the mutations in Si are described below.
Substitutions in the Actin Binding Site. Three sites of substitutions have been identified that lie close to the actin binding interface, R403QLW, V606M, and K615N (Arg-405, Ile-608, and Lys-617 in chicken skeletal MHC). There is an additional site, R663H (Arg-665), on the same face of the protein that might be also involved in actin binding. The three sites are associated with the flat face of the upper domain of the 50-kDa region of the MHC (Figs. 1 and 2 ). Arg-405 in chicken skeletal muscle myosin occurs at the base of a loop that extends away from the bulk of the molecule. This loop has been predicted to be an integral part ofthe actomyosin interface (24) . The observed conformation of the loop is stabilized by an interaction with a symmetry-related molecule. Thus it is likely that this loop will adopt a different conformation in solution and during its interaction with actin. Arg-405 does not participate in any specific interaction with any other amino acid; thus it is possible that this residue is only important when myosin is bound to actin and then could interact directly with actin or contribute to the stability of the loop.
Biochemical studies on the R403Q mutation show that human 1-cardiac myosin containing this mutation exhibits considerably reduced velocity in an in vitro motility assay and a reduced actin-activated MgATPase activity (35) . In addition a rat a-myosin that contained this mutation at the equivalent position also showed lower in vitro motility than wild type and had a reduced Vmax and a higher Km for the actin-activated MgATPase activity (36) . These features are consistent with an altered actomyosin interaction. The V606M (chicken Ile-608) mutation occurs in the chicken skeletal myosin structure shortly after the polypeptide chain crosses over from the lower to the upper segments of the central 50-kDa region. This residue is buried and lies against the upper 50-kDa domain. All of the residues in contact with Ile-608 are identical to those in human 13-cardiac MHC.
Insertion of a methionine side chain into this pocket might destabilize the molecule in this region or alter the structure in the cross-over region.
The equivalent amino acid to the K615N mutation (chicken Lys-617) is a surface residue that is located at the top of the helix-loop-helix motif that contains the V606M mutation described above. It is not obvious what role this residue plays in either the actomyosin complex or protein stability. It is conceivable that it is involved in the actomyosin interaction since it does face into the region between actin and myosin as it has been currently modeled (24) .
R663H (chicken Arg-665) is the fourth member of the mutations located in the actomyosin interface. This residue is located at the end of the first helix in the 20-kDa fragment and is directed toward the proposed actin binding region. In chicken myosin Si, Arg-665 does not participate in a salt-bridge or hydrogen bonding interaction and is solvent-exposed. It is difficult to provide a structural role for this mutation, although it does remove a positive charge from the actomyosin interface.
Mutations near the Nucleotide Binding Site. The active site of chicken skeletal myosin Si contains many completely conserved residues (21) . It would be expected that very few mutations in this region would be compatible with life. Even so, several of the genetic lesions associated with HCM are located directly in the nucleotide binding pocket. One group of these mutations includes T124L, N187K, N232S, and F244L (Thr-125, Asn-188, Asn-234, and Phe-246), all of which are located at the base of the pocket (Fig. 3) .
The side chains of Thr-125 and Asn-188 residues are in close proximity in the structure of chicken skeletal myosin Si (Fig.   3 ). The Oy of Thr-125 is not directly coordinated to any other hydrogen bonding group. Furthermore, it is not within bonding distance of ADP when it is bound to the high salt crystals (A. J. Fisher and I.R., unpublished results). However, these mutations would be expected to alter the water structure in the active site and thus affect the kinetic properties of the protein.
Likewise, Asn-234 and Phe-246 lie in close proximity to each other but are on the opposite side of the phosphate binding loop relative to residues Thr-125 and Asn-188. The side chains for these residues are both buried and are brought together by a turn that connects the sixth strand of the (3-sheet motif in the myosin head to an a-helix (residues 218-233) that forms part of the base of the active site pocket. This loop is adjacent to the phosphate binding loop and contains Ser-243 that has been implicated in nucleotide binding by chemical modification studies with vanadate (37) . This loop forms the second major contact region with the phosphates of the nucleotide (A. J. Fisher and I.R., unpublished results). The side chains of Asn-234 and Phe-246 are not directly involved in phosphate binding. However, both of these residues are in a position to influence the orientation of other residues in the phosphate binding pocket. In particular, Asn-234 forms a hydrogen bond between its NS and the carbonyl oxygen of residue 242, whereas the side chain of Phe-246 forms a stacking interaction with Phe-438. Thus it is expected that any changes in these side chains would alter the position of critical residues in the nucle- A second group of active site mutations is located at the end of the nucleotide binding pocket at a distance of 29 A from the phosphate binding loop (Figs. 2 and 3 ). This group includes Y162C, Q222K, R249Q, G256E, and R453C, which correspond to Tyr-163, Ser-224, Arg-251, Gly-258, and Arg-455 in the chicken myosin sequence. Arg-455 and Arg-251 are located close to each other at the surface of the protein and face toward the putative actin binding region of the molecule and thus might influence this property of the molecule. This could occur by interacting directly with actin or by influencing the closure of the narrow cleft that splits the 50-kDa tryptic fragment. This is because of their close association with the first helix of the C-terminal 20-kDa tryptic fragment that extends across the external interface of the upper and lower domains of the 50-kDa tryptic fragment. Similarly, the side chains for Tyr-163 and Gly-258 are opposite to each other but in this case are somewhat buried. Again the position of these residues suggests that they are located in a domain-domain interface that might be affected when myosin cyclically interacts with actin and nucleotide. Ser-224 is located at the end of the nucleotide binding pocket 23 A from the phosphate binding loop and faces toward the solvent. It does not participate in any hydrogen bonding interactions. This residue is a serine in the structure of chicken skeletal myosin S1 whereas it is a glutamine in the -NMHC. In the structure of chicken skeletal myosin Si, most of the residues surrounding Ser-224 are identical to the equivalent residues in the human ,3-MHC. At present it is difficult to assess the importance of this location in the structure.
Mutations in the Lower Domain of the 50-kDa Fragment, Near the Reactive Sulihydryls. There are two mutations, F513C (chicken Phe-515) and G584R (chicken Gly-586), that are associated with the lower domain of the 50-kDa tryptic fragment (Figs. 3 and  4) . In the native structure, both of these residues are close to the helix that connects the two reactive cysteine residues (Cys-707 and Cys-697). Phe-515 forms a stacking interaction with the side chain of residue 706, whereas Gly-586 is located in a turn that abuts the second reactive cysteine. It is expected that any other residue in this latter location would alter the conformation of this segment and change the domain-domain interactions. Chemical and structural studies of myosin have indicated that there must be a significant structural rearrangement associated with the reactive sulffihydryl groups during the contractile cycle (38) (39) (40) (41) . In the structure of chicken skeletal myosin Si, these two residues are separated by an a-helix where their side chains point in opposite directions (23) , yet they can be cross-linked in the presence of nucleotide (42) (43) (44) and chemical modification of the cysteines changes the kinetic properties of myosin (45, 46) . It has been suggested that domain movements around the reactive sulfhydryl pocket allows the molecule to bend during the contractile cycle without inducing major structural rearrangements within the domains themselves (47) . These two mutated residues lie at such a domain interface and may modify the nature and timing of conformational changes during the contractile cycle.
Mutations in the 20-kDa Tryptic Fragment. There are seven mutations associated with the 20-kDa fragment (Fig. 4) . These are particularly interesting mutations since they highlight an area of the molecule whose importance was not obvious from the initial examination of the x-ray structure (23, 24) . These mutations fall into two groups. The first group consists of G716R, R719WQ, R723C, and G741R, which correspond to residues Ala-718, Lys-721, Arg-725, and Ala-743. These are located in the small domain that follows the reactive cysteines. The first three residues, Ala-718, Lys-721, and Arg-725, lie on the same side of a short a-helix that forms an interface with the ELC. The remaining mutation (G741R) is closely associated with secondary structural elements that form the interface to the ELC.
The second group of mutations in the 20-kDa fragment are located in the long a-helix that forms the light chain binding region of the molecule. These are D778G and S782N (Asp-780 and Ala-784 in chicken). This pair of mutations lies close to the tripartite interface between the N-terminal 25-kDa fragment of the heavy chain, the ELC, and the long a-helix of the 20-kDa fragment. Both sets of mutations suggest that the interface between the heavy chain and the ELC is important for coupling ATP hydrolysis with movement. To our knowledge, no previous biochemical study, prior to the determination of the structure of the myosin head, has suggested that these residues play any role in the transduction of energy from the hydrolysis of ATP into mechanical force. It will be important to investigate in more detail the enzymatic and mechanical properties of these mutants.
Mutations in the Rod. Five mutations have been observed to occur in the a-helical segment (subfragment 2, S2) that connects the myosin head to the back bone of the thick filament. These mutations cast light on the role of this part of the molecule in muscle contraction. It is expected that the myosin heads for these molecules are normal. Since the head alone is sufficient to generate force (19, 48) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) 49) . The mutations do not occur randomly in the structure but, rather, cluster to four discrete localizations in the head and to the proximal portion of S2. Many of the mutations lie at the interface between structural domains and may influence the transduction of chemical energy into movement. The mutations observed in the f3-MHC serve to indicate parts of the molecule that are important for function. They represent a class of molecules that are probably partially impaired and as such highlight the more subtle features of myosin. This implication has been confirmed in biophysical studies of myosin and skinned muscle fibers from human slow muscle that also express j3-MHC (35, 50) .
The observation that mutations lying in different functional regions of the myosin molecule all lead to cardiac hypertrophy suggests that this phenotype is the consequence of the heart's adaptation to impaired contractile function. This is consistent with the recent description of two additional HCM disease genes encoding sarcomere proteins, a-tropomyosin and cardiac troponin T (51) , and with one other chromosomal localization (52) whose corresponding gene is presently unknown.
Clinical expression of HCM is markedly heterogeneous. Some families are characterized by a high penetrance and early onset of the disease, whereas other families show a more benign course (5) . Additionally, within the same family, clinical expression in the heart and skeletal muscle may be quite variable. These findings highlight the importance of modifying genes and environmental factors in determining the severity of HCM caused by a distinct mutation in the individual patient. Further work may establish a relationship among the locations of the mutations, its corresponding functional consequences, and the severity of the associated disease.
